Login to Your Account



Endo, SkyePharma Cease Propofol IDD-D Agreement

By Karen Pihl-Carey


Monday, April 24, 2006
Endo Pharmaceuticals dropped out as SkyePharma plc's North American development partner for Propofol IDD-D, leaving the future of the anesthetic in limbo as the London-based company decides the next steps. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription